Current Controversies and Challenges in Brugada Syndrome
More than three decades since its initial description in 1993, Brugada syndrome remains engulfed in controversy. This review aims to shed light on the main challenges surrounding the diagnostic pathway and criteria, risk stratification of asymptomatic patients, pharmacological and interventional ris...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/924ef43354f64c3f9518a0efa09e1a0e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:924ef43354f64c3f9518a0efa09e1a0e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:924ef43354f64c3f9518a0efa09e1a0e2021-12-04T16:01:52ZCurrent Controversies and Challenges in Brugada Syndrome10.15420/ecr.2019.12.21758-37641758-3756https://doaj.org/article/924ef43354f64c3f9518a0efa09e1a0e2019-12-01T00:00:00Zhttps://www.ecrjournal.com/articles/Current-Controversies-Challenges-Brugada-Syndromehttps://doaj.org/toc/1758-3756https://doaj.org/toc/1758-3764More than three decades since its initial description in 1993, Brugada syndrome remains engulfed in controversy. This review aims to shed light on the main challenges surrounding the diagnostic pathway and criteria, risk stratification of asymptomatic patients, pharmacological and interventional risk modification strategies as well as our current pathophysiological understanding of the disease.Afik D SnirHariharan RajuRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENEuropean Cardiology Review , Vol 14, Iss 3, Pp 169-174 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
Diseases of the circulatory (Cardiovascular) system RC666-701 Afik D Snir Hariharan Raju Current Controversies and Challenges in Brugada Syndrome |
description |
More than three decades since its initial description in 1993, Brugada syndrome remains engulfed in controversy. This review aims to shed light on the main challenges surrounding the diagnostic pathway and criteria, risk stratification of asymptomatic patients, pharmacological and interventional risk modification strategies as well as our current pathophysiological understanding of the disease. |
format |
article |
author |
Afik D Snir Hariharan Raju |
author_facet |
Afik D Snir Hariharan Raju |
author_sort |
Afik D Snir |
title |
Current Controversies and Challenges in Brugada Syndrome |
title_short |
Current Controversies and Challenges in Brugada Syndrome |
title_full |
Current Controversies and Challenges in Brugada Syndrome |
title_fullStr |
Current Controversies and Challenges in Brugada Syndrome |
title_full_unstemmed |
Current Controversies and Challenges in Brugada Syndrome |
title_sort |
current controversies and challenges in brugada syndrome |
publisher |
Radcliffe Medical Media |
publishDate |
2019 |
url |
https://doaj.org/article/924ef43354f64c3f9518a0efa09e1a0e |
work_keys_str_mv |
AT afikdsnir currentcontroversiesandchallengesinbrugadasyndrome AT hariharanraju currentcontroversiesandchallengesinbrugadasyndrome |
_version_ |
1718372749693419520 |